IBUPHIL 600MG

Its indications in adults (over 15 years of age) are limited to:

– long-term symptomatic treatment of chronic inflammatory rheumatic diseases, including rheumatoid arthritis, ankylosing spondylitis, or related syndromes such as Fiessinger-Leroy-Reiter syndrome and psoriatic arthritis, as well as certain painful and disabling osteoarthritis;

– short-term symptomatic treatment of acute exacerbations of: periarticular rheumatism (such as scapulohumeral periarthritis, tendinitis, bursitis), osteoarthritis, microcrystalline arthritis, low back pain, radiculalgia, and mild post-traumatic acute conditions of the musculoskeletal system;

– dysmenorrhea, after ruling out an underlying cause;

– symptomatic treatment of mild to moderate pain and/or fever.

Category:

Description

Speciality IBUPHIL 600
Dosage 600 mg
Form Film-coated tablet
Packaging Box of 20
Primary packaging Blister
Specification ALU, PVC
INN (International Nonproprietary Name) IBUPROFEN
VEIC classification Essential
Therapeutic class MUSCLE AND SKELETON
Sub-class ANTI-INFLAMMATORY AND ANTIRHEUMATIC AGENTS
Laboratory SIMED
Schedule C
Shelf life 36 months
Generic/Brand Generic
Marketing Authorization Number 9083455
Marketing Authorization Date 2010-01-13
Range Pain Range, Pediatrics

Reviews

There are no reviews yet.

Be the first to review “IBUPHIL 600MG”

Your email address will not be published. Required fields are marked *